SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-099836
Filing Date
2017-03-28
Accepted
2017-03-28 16:30:07
Documents
10
Period of Report
2017-05-12
Effectiveness Date
2017-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d309056ddef14a.htm DEF 14A 420610
2 GRAPHIC g309056g03a30.jpg GRAPHIC 27548
3 GRAPHIC g309056g03k29.jpg GRAPHIC 27352
4 GRAPHIC g309056g17w99.jpg GRAPHIC 36986
5 GRAPHIC g309056g36u31.jpg GRAPHIC 30381
6 GRAPHIC g309056g50q05.jpg GRAPHIC 26386
7 GRAPHIC g309056g69f98.jpg GRAPHIC 25946
8 GRAPHIC g309056g86q68.jpg GRAPHIC 34412
9 GRAPHIC g309056pc001.jpg GRAPHIC 101692
10 GRAPHIC g309056pc002.jpg GRAPHIC 82056
  Complete submission text file 0001193125-17-099836.txt   956337
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36329 | Film No.: 17719311
SIC: 2834 Pharmaceutical Preparations